Extension Study of ABP-671 in Participants With Gout

NCT06276556 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
43
Enrollment
INDUSTRY
Sponsor class

Stopped For business consideration, a new long-term safety study will be conducted in the next new pivotal studies.

Conditions

Interventions

Sponsor

Atom Therapeutics Co., Ltd